The WACC of Codiak BioSciences, Inc. (CDAK) is 8.2%.
Range | Selected | |
Cost of equity | 12.60% - 17.70% | 15.15% |
Tax rate | 26.20% - 27.00% | 26.60% |
Cost of debt | 7.00% - 11.80% | 9.40% |
WACC | 6.3% - 10.1% | 8.2% |
Category | Low | High |
Long-term bond rate | 4.2% | 4.7% |
Equity market risk premium | 5.0% | 6.0% |
Adjusted beta | 1.68 | 2.1 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 12.60% | 17.70% |
Tax rate | 26.20% | 27.00% |
Debt/Equity ratio | 5.33 | 5.33 |
Cost of debt | 7.00% | 11.80% |
After-tax WACC | 6.3% | 10.1% |
Selected WACC | 8.2% | |